Transjugular Intrahepatic Portosystemic Shunt
|
|
- Mabel Barker
- 5 years ago
- Views:
Transcription
1 카J Korean Radiol Soc 1997; 36 : Transjugular Intrahepatic Portosystemic Shunt Results and Prognostic Factors in Patients with Post-necrotic Liver Cirrhosis 1 Jae Hyung Park, M.D., Yong Joo Kim, M.D. 2, Jin Wool Chung, M.D. Joon Koo Han, M.D., Man Chung Han, M.D. Purpose : To evaluate the effectiveness of transjugular intrahepatic portosystemic shunt(tips) in the management of gastroesophageal variceal bleeding and predictive factors for long-term survival in patients with post-necrotic liver cirrhosis. Materials and Methods : A total of 49 patients with post-necrotic liver cirrhosis underwent TIPS over a recent three-year period. Forty-five had a history ofhepatitis B viral infection, and four, ofhepatitis c viral infection. In all patients, the indication for the procedure was variceal bleeding. Child-Pugh class was A in seven patients, B in 16 and c in 26 patients at the time ofthe last bleeding. The effectiveness ofportal decompression and bleeding control was evaluated. Long-term survival was calculated by the Kaplan-Meier method and predictive factors were analyzed using the Wilcoxon test. Results : The procedure was technically successful in all cases. The portosystemic pressure gradient decreased significantly from 21.4::!: 6.4mmHg to 12.0::!: 5.1 mmhg (N=45). Active variceal bleeding was controlled in 34 of the 37 emergency patients. The totallength of follow-up was from one day to three and a half years(mean: 383:!: 357 days). Rebleeding developed in 17 patients (35 %). Hepatic encephalopathy, either newly developed or aggravate,d, occurred in 16(32.7 %). The thirty-day mortality rate was 20.4%, and the one-year survival rate was 63.8 %. The significant predictive factors for poor prognosis were Child-Pugh class c and post-tips hepatic encephalopathy. Conclusion : TIPS is effective in portal decompression in the patients with variceal bleeding due to post-necrotic liver cirrhosis. The Child-Pugh classification and hepatic encephalopathy after TIPS are considered to be significant predictive factors for long-term survival. Index Words : Hypertension, portal Liver, cirrhosis Liver, interventional procedure Shunts, portosystemic Introduction Transjugular intrahepatic portosystemic shunt 'Department of Radiology. Seoul National University Coll ege of Medicine ' Department of Ra diology. Ky ungbook National University Co llege of Medi cine. Taegu, Korea Received August ; Accepted October Ad dress reprint requests to: Jae Hyung Park, M.D., Department of Radiology Seoul National Un iversity College of Medicine, # 28 Yongon-Dong Chongno-Ku, Seoul Korea (TIPS) has been reported as an alternative to sclerotherapy or surgical portosystemic shunt in the treatment of acute variceal bleeding in liver cirrhosis patients (1-3). In many Asian countries, the majority of liver cirrhosis is due to hepatitis B or C viral infection, while in western countries it is due to alcoholic abuse (4). To our knowledge, there have been few reports of portal decompression using the TIPS procedure in patients with post-necrotic liver cirrhosis. Because of differing etiologies of liver cirrhosis, there
2 Jae Hyung Park, et al : Transiugular Intrahepatic Portosystemic Shunt might be differences in procedural techniques, the effectiveness of portal decompression, frequency of rebleeding, and shunt related complications In order to evaluate the effectiveness of TIPS in the management of gastroesophageal variceal bleeding and long-term survival in patients with post-necrotic liver cirrhosis, we retrospectively reviewed clinical and radiological data ofthose patients. Materials and Methods Patients Of 70 patients who underwent TIPS procedure during the three years from June 1991 to April 1994, 49 were suffering from post-necrotic liver cirrhosis. Thirty-four were men and 15 were women ; their mean age was 49 years (range, 30-69). All patients had a history of between one and nine variceal bleeding episodes (mean 2.9 times). There was endoscopic evidence of esophageal or esophagogastric varices(n = 20 ; N = 26, respectively). In three patients, only gastric varices were detected. Congestive gastropathy was associated with gastric varices in three, and with esophageal varices in two. The serologic criteria ofprevious viral infection were positive surface antigen and core antibody for hepatitis B infection, and positive antibody for hepatitis C viral infection. There was evidence of previous hepatitis B viral infection in 45 patients and of hepatitis C viral infection in four. The liver function reservoir at the time of the last bleeding was estimated by the Child-Pugh modified scoring system. Child-Pugh class was A in seven patients, B in 16 and C in 26 patients, and 30 were positive for ascites. Imaging diagnoses including sonography (N=49), CT (N=25) and arterial portography (N=16), were performed to assess liver size, portal vein patency and the presence of associated hepatomas. In all cases, endoscopically confirmed bleeding from esophageal or gastric varices was the indication oftips procedure. In these cases, endoscopic sclerotherapy had failed to control the gastric or esophageal varices. The pro cedure was performed on an emergency basis for active bleeding in 37 patients and was elective in 12. In seven Child-Pugh class A patients, the procedure was performed electively in three patients and on an emergency basis in four, because of active bleeding from esophageal or gastric varices. Procedure The right internal jugular vein was. punctured at the middle of the right neck. After introducing a 9-F arterial sheath (Cook Bloomington, Ind) into the jugular vein, an angiographic catheter was inserted into either the right or middle large hepatic vein. We punctured blindly with Colapinto needle in the initial stage (N=31), but in later stages punctures were guided by a fine guide-wire inserted in the right and main portal vein via the percutaneous transhepatic route (N = 12) To demonstrate the portal system, however, we have recently performed superior mesenteric arterial portography (N=6) with or without transfemoral fine guide-wire in the right hepatic via the celiac artery. In all 49 cases, the stent shunt was constructed successfully. Shunts were from the right hepatic (N=35) to the right portal vein (N=27), to the portal bifurcation (N=5), or to the left portal vein (N=3). The shunt was from the middle hepatic (N= 12), to the right portal (N=lO), or to the left portal vein (N=2) (Fig. 1), or from left hepatic to the left portal vein (N=2) Pressure was measured at the main portal vein and hepatic venous pressure was measured through the sheath after pull-back. Portography was performed with a catheter in the splenic and superior mesenteric veins. The balloon was positioned across the parenchymal tract and dilated. In 47 patients we used Wallstent (Schneider, Switzerland). A 7F Wallstent r 빼 A / J 빼 B m 1 률 ; 철닐 Fig. 1. Forty-year-old male patient 1 멸 11. with post-necrotic liver cirrhosis... and variceal bleeding. After punc., ture of left portal vein from middle ' hepatic vein, portal venography was performed. Multiple gastric varicose veins were revealed (A) After creation of shunt between middle hepatic vein and right portal vein with Wallstent, lomm in di J ameter, effective portal decom.. pression was obtained. The portosy,... stemic gradient was 9mmHg (B).
3 J Korean Radiol Soc 1997; 36 : was used. Ifthere was still significant hepatofugal flow into the varices, metallic coil embolization with or without Gelfoam pellets was selectively applied to the varices especially in cases with incomplete portal decompression. To evaluate shunt patency, follow-up duplex sonography was performed every three month. Data anajysis Technical success was defined as the construction of a stent shunt between the hepatic and portal veins and effective portal decompression with a portosystemic pressure gradient less than 15mmHg after the procedure. Successful bleeding control was defined as cessation of bleeding within 24 hours after TIPS. Rebleeding was defined as a new episode of gastrointestinal hemorrhage occurring more than 24 hours of TIPS. The severity of encephalopathy was graded as o-n, based on level of consciousness, intellectual function, and neurologic abnormalities (5). The effectiveness of TIPS for portal decompression and bleeding control was evaluated. Thirty-day mortality and long-term survival were calculated by the Kaplan-Meier method and prognostic factors were analyzed with a pc-sas 6.04 and an IBM compatible PC. Various potential prognostic factors such as the Child-Pugh classification (A & B versus C), emergency versus elective basis ofthe procedure, stent size (8mm n 1 versus 10 아mm미 1 s잉 i펴 dua떠 1 po야 rta 려 vein pressure > 20 아mmHg versus < 20 mmhg), rebleeding (positive versus negative) and post-tips encephalopathy (positive versus negative) were evaluated in terms of the influence of prognostic factors on survival rate. The Wilcoxon test was used for statistical evaluation ofthe groups. Results PortaJ decompression Hemodynamic data was available for 45 patients Portal vein pressure before shunt creation was 29.2 :t 7.0 mmhg and the hepatic vein pressure was 7.8 :t 4.7 mmhg after TIPS procedure ; these changed to 20.3 :t 6.2mmHg and 8.3 :t 5.2mmHg, respectively. The portosystemic gradient improved from 21 :t 6.4mmHg before the procedure to 12.0 :t 5.1 mmhg after ; even in the seven of nine patients with an 8mm stent, the pressure gradient significantly improved from 21.3 :t 4.3mmHg to 13.0 :t 5.7mmHg. Coil embolizations for varices that persisted after TIPS were performed in 12 cases, with additional Gelfoam embolization in two. Successful TIPS creation resulted in control of acute variceal bleeding in 34 cases (92 %) among the 37 emergency patients. Effective portal decompression with a portosystemic pressure gradient of less than 15 mmhg was obtained in 35 ofthe 49 patients (78 %) (Fig. 1). RebJeeding Rebleeding occurred in 17 patients(35 %) during the follow-up period of three and a half years. Rebleeding started within six months in 15 patients, 8 months later in one case, and 2.2years later in one case. Follow-up evaluation with transjugular portal venography revealed stent occlusion in both patients ; redilation of the shunt tract and shunt surgery were successfully performed in both cases. In six of the 15 patients who experienced rebleeding within six months, this occurred within one month of TIPS. The causes of rebleeding in six cases were pre-existing portal vein thrombosis (N=2), acute thrombotic occlusion (N=I) and unknown etiology (N=3). Of the six, only two were successfully controlled by shunt surgery and endoscopic sclerotherapy. The remaining nine cases (18 %) underwent shunt stenosis on transjugular portal venography at the time of rebleeding. In two cases, redilatation of the stent shunt with a balloon catheter was successful in controlling the second bleeding. A second Wallstent was inserted into the first stent shunt in two cases, and in two patients a new second stent shunt was created after making a new tract. In three cases surgery was performed to make a splenorenal shunt. In one case, the shunt was occluded due to portal vein thrombosis, 없 ld in the remaining two cases, rebleeding developed due to stent occlusion. Two patients underwent sclerotherapy and conservative treatment ; in three cases, death ensued due to rebleeding. Hepatic encephajopathy Before the procedure, thirteen patients had hepatic encephalopathy, and in 16 cases (32.7 %) it was aggravated (N=7) or newly developed (N=9) after creation of the intrahepatic shunt. Various degrees of hepatic encephalopathy were present in 20 patients after the procedure. In ten ofthese, conservative treatment with lactulose was effective in controlling the symptoms. In six, however, hepatic encephalopathy progressed and death d ue to hepatic coma ensued within one moqth. Other compj ications In patients with post-necrotic liver cirrhosis, there were several complications other than hepatic encephalopathy and rebleeding after creation of TIPS. These were acute renal failure (N= 2), hemoperitoneum
4 Jae Hyung Park, et al : Transiugular Intrahepatic Portosystemic Shunt catheter was positioned across the tract and the stent was deployed so that it covered the tract and extended 1-3 cm into the hepatic and portal veins. In nine patients, the diameter ofthe stent was 8mm and in 42 it was lomm. An 8-mm balloon was inserted and inf1ated in the stent. Portal vein pressure was measured and if the portal decompression was not satisfactory, a 10mm balloon (N=l), pulmonary edema (N= l), sepsis (N=l), and progressive hepatic failure (N=4). In the patient with hemoperitoneum, f1uoroscopy during the procedure showed extravasation to the peritoneum due to a hepatic capsular puncture ; he died three days later. Long-term surv;val At the end of May 1994, 24 patients had died, 22 were alive and three were no longer included in survival calculation. None of these patients had undergone a liver transplantation. The three who dropped out had undergone a surgical shunt operation after the failure of effective portal decompression with TIPS. The follow-up period of the 49 patients was from one day to three and a half years (mean 383 ::!::: 357 days). The overall one year survival rate, calculated by the Kaplan-Meier method, was 63.8 % and the thirty-day mortality rate was 20.4 %. The causes of death were progressive hepatic failure or hepatic coma (N=9), rebleeding (N=9), renal failure (N=2), hemoperitoneum (N= 1), sepsis (N= 1) and unknown causes (N=2). Prognost;c factors Among many prognostic factors, Child-Pugh class and hepatic encephalopathy were significant. The survival rate of Child-Pugh class A and B patients (mean 633 days) was significantly better than that of Child-Pugh class C patients (mean 279 days), as determined by Wilcoxon analysis (p = ). The one year survival rate of Child-Pugh class A or B patients was 90.0 %, significantly better than the rate of 40.8 % for those who were Child-Pugh class C (Fig. 2). The thirty-day mortality rate ofchild-pugh class A or B patients, 4.4 %, was significantly lower than the rate of 34.6 %, noted for those who were Child-Pugh class C. The survival rate of elective cases was significantly better than that of emergency cases. The presence of hepatic encephalopathy after TIPS, either aggrevated status of preexisting one or newlydeveloped one, was a significant predictive factor for poor prognosis. The mean survival period of patients without hepatic encephalopathy was 450 days, significantly better than the 289 days of those with this condition (p=0.0093) (Fig. 3). All other potential prognostic factors were not significant(table 1). Discussion TIPS has been accepted as a portal decompression procedure in the management ofvariceal bleeding and the efficacy of the procedure has been proven in various types of liver cirrhosis (1-3). The postnecrotic liver, especially after hepatitis B viral infection, is typically shrunken, distorted in shape, and composed of nodules of liver cells separated by dense and broad bands of fi brosis (6). The right hepatic encephalopathy (-) Child C o DIl\ Fig. 2. Long-term survival curve of patients with postnecrotic cirrhosis after TIPS. The survival rate of patients with Child-Pugh class A and B was significantly higher than that of patients with Child-pugh class C o Day Fig. 3. Long-term survival curve of patients with postnecrotic cirrhosis after TIPS. The survival rate of patients with presence of hepatic encephalopathy after TIPS was significantly lower than that of patients without hepatic encephalopathy after TIPS
5 J Korean Radiol Soc '997; 36: Table 1. Variables and Groups in Consideration of Prognostic Factors of TIPS in 49 Patients with Post-necrotic Liver Cirrhosis Variables N Grups I n m P value+ Child-Pugh classification 49 Class A & B (47 %) Class C (53 %) * Endoscopic grade of esophaged varix 49 Grade 0-1 (14 %) Grade II (29 %) Grade ]]J (57 %) Stent diameter 49 8mm (18 %) 10mm (82 %) Post-TIPS portal vein pressure 45 늘 20mmHg (56 %) 20mmHg (44 %) Post-TIPS portosystemic gradient 45 > 12mmHg (42 %) < 12mmHg (58 %) Rebleeding 49 Positive (29 %) Negative (71 %) Post-TIPS hepatic encephalopathy 49 Positive (43 %) Negative (57 %) * + P value by Wilcoxon method, * statistically significant < 0.05 vein sometimes becomes sma11 and narrow due to the shrunken right lobe of the liver. Even with such anatomic distortion, TIPS could be created in a11 patients with post-necrotic liver cirrhosis. In many Asian countries, liver transplantation has not been widely accepted, so TIPS procedure is used only for the purpose of permanent portal decompression, not for the bridging procedure before a subsequent liver transplant. Long-term survival after TIPS is, therefore, important in these patients. There have been many reports of successful portal decompression after TIPS that resulted in a significantly lower residual pressure gradient between the portal and hepatic veins (1-3); after successful TIPS, the mean residual portosystemic gradient was usua11y lower than 12mmHg. In recent TIPS reports, most cases were Laennecs cirrhosis (1-3). In this series with post-necrotic cirrhosis, a high technical success rate was also obtained. The technique for creating a stent shunt between the hepatic and portal veins was diffi cult in those cases with severe atrophy ofthe right lobe due to post-necrotic liver cirrhosis, and the resulting anatomical distortion may have resulted in relatively poor maintenance ofthe shunt. Emergency TIPS successfu11y contro11ed acute variceal bleeding in a11 except three patients. The incidence of rebleeding was reported to be between 6.7 and 36 % (7); it developed in 17 patients(35 %) in our series, mostly within one month of TIPS. The main cause of rebleeding was considered to be restenosis of stent shunt, which was successfu11y managed in six cases. The relatively high incidence of early rebleeding in our series seemed to be due to coagulopathy in those patients who were Child-Pugh class C. In addition to hepatoce11ular carcinoma and bleeding varices, hepatic encephalopathy is one of the serious sequelae of the progressive post-necrotic liver cirrhosis. It is also one of the serious complications of TIPS and its frequency has been reported as being between 5 and 35 % (7). In a series of 100 patients, LaBerge et a1. reported 17 with new or aggravated hep atic encephalopathy out of a total of 96 patients who had successfu11y undergone TIPS (2). In our series, the incidence of hepatic encephalopathy was 32.7 %, relatively high compared to previous reports. In many of our patients it was most likely due to poor liver function, Child-Pugh class C. Ofthe 14 patients with new or aggravated hepatic encephalopathy, eight died because of progressive hepatic failure and hepatic coma. Excluding hepatic encephalopathy and delayed stenosis or occlusion of the stent, the overa11 complication rate in the report of LaBerge et a1. was less than 10 %. Complications were related to techniques, stents or contrast media (7). In our series, complications other than hepatic encephalopathy and rebleeding were hemoperitoneum, renal failure, pulmonary edema and sepsls. We assumed many potential prognostic factors, such as Child-Pugh classification, emergency or elective basis for the procedure, stent size, post-procedural hemodynamic data, rebleeding, and post-tips encephalopathy. Of these, Child-Pugh class and hepatic post-procedural encephalopathy were significant prognostic factors in multivariate analysis. In any treatment modality the prognosis of Child-Pugh class C patients is very poor. The reported operative mortality rate associated with surgical portocaval shunts in cir rhotic patients who are Child-Pugh class C is as high as 50 % (8). LaBerge et a1. reported that the 30-day mor tality rate after TIPS was 24 % in Child-Pugh class C patients (2). In our series, the survival rate of such patients was very poor with a mean survival period of 279 days ; due to hepatic coma, failed bleeding control and other complications, the 30-day mortality rate of Child-Pugh C patients was as high as 34.6 %. A11 except one of such patients underwent the procedure on an 41
6 Jae Hyung Park, et al : Transiugular Intrahepatic Portosystemic Shunt emergency basis. In summary, TIPS is considered to be effective in portal decompression in patients with variceal bleeding due to post-necrotic liver cirrhosis. The overall one year survival rate after TIPS is 63.8 % in patients with post-necrotic liver cirrhosis. During long-term followup, it should be considered that the significant prognostic factors are Child-Pugh classification and post TIPS hepatic encephalopathy. References 1. Richter GM, Noeldge G, Palmaz JC, et aj. Transjugular intrahepatic stent shunt: preliminary clinical results. Radiology 1990; 174: LaBerge JM, Ring EJ, Gordon RL, et aj. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis : results in 100 patients. Radiology 1993; Hausegger KA, Sternthal HM, Klein GE, Karaic R, Stauber R, Zenker G. Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions. Radiology 1994; 191: Podolsky DK, Isselbacher KJ. Cirrhosis. In. Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS ed. Harrison s Principles of Internal Medicine. 11 th ed. New York, McGraw-Hill Book Company, 1987; Schafer DF, Jones EA. Hepatic encephalopathy. In: Zakim D and Boyer TD, ed. Hepatology. 2nd ed. Philadelphia: W. B Saunders Company, 1990 ; Edmondson HA, Peters RL. Liver. In Kissane JM, ed Anderson' s Pathology. 8th ed. St. Louis, Toronto, Princeton. The c. V. Mosby Company, 1985; Freedman AM, Sanyal AJ, Tisnado J, et aj. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. RadioGraphics 1993; 13: Cello JP, Grendel JN, Crass RA, et al. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl Med 1984; 311 : Warren WD, Henderson JM, Millikan WJ, et aj. Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Ann Surg 1986; 203 : 대한방사선의학호 IXI 1997; 36: 경경정맥간내문맥간정맥단락술 : 괴사후간경변환자에서의성적과예후인자 1 l 서울대학교의과대학방사선과학교실 2 경북대학교의과대학방사선과학교실 박재형 검용주 2 정진욱 한준구 한만청 목적 : 목정맥을통한간내문맥간정맥단락술 (TIPS) 을이용한괴사후간경변환자의위 식도정맥류출혈치료에있어서그성적과예후인자를알아보고자한다. 대상및방법 : 최근 3년간 TIPS시술을받은괴사후간경변환자 49 명을대상으로하였다. 이들중 B 형감염표식자양성환자는 45 명이었고 C 형간염표식자양성은 4 명이었다. 전례에서시술의적응증은위 식도정맥류출혈이었다. 시술전최종출혈시 Child-Pugh 분류는 A가 7 명, B가 16 명, C 가 26 명이었다. 시술에의한문맥감압과지혈효과를분석하였으며 Kaplan-Meier 방법으로 TIPS 시술후의장기생존율을구하였으며 Wilcoxon 테스트로서예후인자를검정하였다. 결과시술은전례에서기술상성공하였다. 문맥체정맥압력차가시술전 21.4 :t 6.4 mmhg에서수술후 12.0 :t 5.1mmHg (N = 45) 로감소하였다.37 명의응급환자중 34 명에서정맥류의활동성출혈이지혈되었다. 추적기간은 3년 6 개월 ( 평균 383 :t 357 일 ) 이였으며이기간중재출혈은 17 명 (35%) 에서있었고간성뇌병증은 16 명 (32.7%) 에서새로나타나거나악화되었다.30 일사망율은 20.4% 이며일년생존율은 63.8% 이었다. 예후가불량할것으로예상할수있는예후인자는 Child-Pugh 분류 C 와시술후의간성뇌병증이었다. 결론 : TIPS 는위 식도정맥류출혈이있는괴사후간경변환자에있어서효과적인문맥감압방법이다. 의미있는예후인자는 Child-Pugh 분류 C 와시술후의간성뇌병증이었다
Tranjugular Intrahepatic Portosystemic Shunt
Tranjugular Intrahepatic Portosystemic Shunt Christopher Selhorst July 25, 2005 BIDMC Radiology Overview Portal Hypertension Indications, Contraindications The Procedure Case Review Complications Outcomes
More informationBarbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana
STROKOVNI SESTANEK ZDRUŽENJA HEMATOLOGOV SLOVENIJE IN ZDRUŽENJA ZA TRANSFUZIJSKO MEDICINO, Terme Zreče, 17.-18.4.2015 Barbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana goals,
More informationMichele Bettinelli RN CCRN Lahey Health and Medical Center
Michele Bettinelli RN CCRN Lahey Health and Medical Center Differentiate the types of varices Identify glue preparations utilized when treating gastric varices Review the process of glue administration
More informationTransjugular Intrahepatic Portosystemic Shunt in Patients with Active Variceal Bleeding Due to Portal Hypertension and Portal Vein Thrombosis I
J Korean Radiol Soc 1997; 37 : 597-603 Transjugular Intrahepatic Portosystemic Shunt in Patients with Active Variceal Bleeding Due to Portal Hypertension and Portal Vein Thrombosis I Hyun Woong Shin, M.D.,
More informationTransjugular Intrahepatic
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Clinical and Procedural Review Mark R. Werley, M.D. and John Briguglio, M.D. Lancaster Radiology Associates, Ltd. INTRODUCTION This article reviews
More informationVirtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,
More informationTranscaval TIPS in Patients with Failed Revision of Occluded Previous TIPS
Transcaval TIPS in Patients with Failed Revision of Occluded Previous TIPS Chang Kyu Seong, MD Yong Joo Kim, MD Tae Beom Shin, MD Hyo Yong Park, MD Tae Hun Kim, MD Duk Sik Kang, MD Index terms: Hypertension,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes
More informationSurgical Rescue of Surgical Failures
HPB Surgery, 1999, Vol. 11, pp. 151-155 Reprints available directly from the publisher Photocopying permitted by license only (C) 1999 OPA (Overseas Publishers Association) N.V. Published by license under
More informationEvidence-Base Management of Esophageal and Gastric Varices
Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National
More informationNYU School of Medicine Department of Radiology Rotation-Specific House Staff Evaluation
Vascular & Interventional Radiology Rotation 1 Core competency in vascular and interventional radiology during the first resident rotation consists of clinical objectives, technical objectives and image
More informationVARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.
VARICEAL BLEEDING Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta Disclosures: None OUTLINE Pathophysiology of portal hypertension Splanchnic
More informationEun-Ju Kang, M.D., Seong Kuk Yoon, M.D., Sang-Hyeon Kim, M.D., Jin Han Cho, M.D., Myong Jin Kang, M.D., Byeong-Ho Park, M.D.
Bleeding from an Ileal Conduit Stomal Varix: Diagnosis with Three- Dimmensional Volume Rendered Images by the use of Multidetector-Row CT (MDCT) and Management with a Transjugular Intrahepatic Portosystemic
More informationTransjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
CLINICAL IMAGES Ochsner Journal 17:311 316, 2017 Ó Academic Division of Ochsner Clinic Foundation Transjugular Intrahepatic Portosystemic Shunt Reduction for Management of Recurrent Hepatic Encephalopathy
More informationUse of transjugular intrahepatic portosystemic shunt in liver disease
Vol. XVIII No. 3 JOURNAL OF VASCULAR NURSING PAGE 83 Use of transjugular intrahepatic portosystemic shunt in liver disease Patricia Ann Radovich, RN, MSN, CCRN, FCCM Persons with cirrhosis have many complications.
More informationTIPS. D Patch Royal Free Hospital London UK
TIPS D Patch Royal Free Hospital London UK TIPS Technique Ascites Budd Chiari Variceal Bleeding Historical Experimental Development 1967 Piccone Shunt between recanalized umbilical vein and saphenous
More informationPortogram shows opacification of gastroesophageal varices.
Portogram shows opacification of gastroesophageal varices. http://clinicalgate.com/radiologic-hepatobiliary-interventions/ courtesyhttp://emedicine.medscape.com/article/372708-overview DR.Thulfiqar Baiae
More informationPORTAL HYPERTENSION. Tianjin Medical University LIU JIAN
PORTAL HYPERTENSION Tianjin Medical University LIU JIAN DEFINITION Portal hypertension is present if portal venous pressure exceeds 10mmHg (1.3kPa). Normal portal venous pressure is 5 10mmHg (0.7 1.3kPa),
More informationTransjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding in Patients with Viral Liver Cirrhosis: Predictors of Early Mortality
Early Mortality with TIPS for Variceal Bleeding Interventional Radiology Original Research Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding in Patients with Viral Liver Cirrhosis:
More informationAASLD PRACTICE GUIDELINE. The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Preamble.
AASLD PRACTICE GUIDELINE The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension Thomas D. Boyer 1 and Ziv J. Haskal 2 Preamble The recommendations in this article
More informationPreliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS
Preliminary study of the permeability and safety of covered stents-grafts in pediatric TIPS Poster No.: C-0354 Congress: ECR 2013 Type: Scientific Exhibit Authors: A. Bueno Palomino, L. Zurera Tendero,
More informationCurrent status of hepatic surgery in Korea
Korean J Hepatol. 2009 Dec; 15(Suppl 6):S60 - S64. DOI: 10.3350/kjhep.2009.15.S6.S60 Current status of hepatic surgery in Korea Kyung Sik Kim Department of Surgery, Severance Hospital, Yonsei University
More informationBRTO /PARTO Indications and outcomes
BRTO /PARTO Indications and outcomes Saher Sabri, MD Associate Professor of Radiology and Surgery Division of Interventional Radiology University of Virginia Health System Saher Sabri, M.D. Speakers Bureau:
More informationWithin-patient temporal variance in MELD score and impact on survival prediction after TIPS creation
Survival prediction after TIPS creation., 2013; 12 (5): 797-802 ORIGINAL ARTICLE September-October, Vol. 12 No.5, 2013: 797-802 797 Within-patient temporal variance in MELD score and impact on survival
More informationAcute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosis
Interventional Medicine & Applied Science, Vol. 7 (4), pp. 166 170 (2015) CASE REPORT Acute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosis
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,
More informationSpontaneous portosystemic venous shunts in liver cirrhosis: Anatomy, pathophysiology, hemodynamic changes and imaging findings
Spontaneous portosystemic venous shunts in liver cirrhosis: Anatomy, pathophysiology, hemodynamic changes and imaging findings Poster No.: C-3193 Congress: ECR 2010 Type: Educational Exhibit Topic: Vascular
More informationLongterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients
Gut 1996; 39: 479-485 Departments of Medicine A J Stanley R Jalan E H Forrest P C Hayes and Radiology D N Redhead Royal Infirmary of Edinburgh, Edinburgh Correspondence to: Dr A J Stanley, Department of
More informationU cause of death in patients with end-stage liver
Transjugular Intrahepatic Portosystemic Shunt in Patients With End-Stage liver Disease: Results in 85 Patients- Nicolas Jabbour, * Albert?. Zajko, # Philip D. Orons, # William Irish, * Fabio Bartoli, *
More informationContraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:
Contraindications Absolute Relative Primary prevention variceal bleeding HCC if centrally located Active congestive heart failure Obstruction all hepatic veins Thomas D. Boyer, M.D. University of Arizona
More informationMesocaval Shunt Creation for Jejunal Variceal Bleeding with Chronic Portal Vein Thrombosis
Case Report Yonsei Med J 2018 Jan;59(1):162-166 pissn: 0513-5796 eissn: 1976-2437 Mesocaval Shunt Creation for Jejunal Variceal Bleeding with Chronic Portal Vein Thrombosis Ja Kyung Yoon 1, Man-Deuk Kim
More informationINSTRUCTIONS FOR USE FOR: English
INSTRUCTIONS FOR USE FOR: en English dk TABLE OF CONTENTS DESCRIPTION...1 INTENDED USE/INDICATIONS FOR USE...2 CONTRAINDICATIONS...2 WARNINGS...2 PRECAUTIONS...3 MAGNETIC RESONANCE IMAGING (MRI)...3 ADVERSE
More informationV ariceal haemorrhage is a major cause of mortality and
270 LIVER DISEASE The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric : clinical and haemodynamic correlations D Tripathi, G Therapondos, E
More informationClinical Study Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
Gastroenterology Research and Practice, Article ID 659726, 8 pages http://dx.doi.org/10.1155/2014/659726 Clinical Study Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension
More informationIntrahepatic Portosystemic Venous Shunt: Successful Embolization Using the Amplatzer Vascular Plug II
Case Report http://dx.doi.org/10.3348/kjr.2012.13.6.827 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(6):827-831 Intrahepatic Portosystemic Venous Shunt: Successful Embolization Using the Amplatzer
More informationBRTO: Updates to Techniques
Session XIV: BRTO, PARTO and Portal Hypertension GEST2016 BRTO: Updates to Techniques Hiro Kiyosue Oita University Hospital, Japan Hiro Kiyosue, MD Royalty: Cook, Medkit Consulting Fee: Stryker Japan,
More informationPercutaneous transsplenic catheterization of the portal venous system
Acta Radiologica ISSN: 0284-1851 (Print) 1600-0455 (Online) Journal homepage: https://www.tandfonline.com/loi/iard20 Percutaneous transsplenic catheterization of the portal veus system H.-L. Liang, C.-F.
More informationEndovascular Techniques for Symptomatic Portal Hypertension. Michael Meuse, M.D. Vascular and Interventional Radiology
Endovascular Techniques for Symptomatic Portal Hypertension Michael Meuse, M.D. Vascular and Interventional Radiology Objectives Review indications and contraindications for TIPS Define a treatment algorithm
More informationObliterative hepatocavopathy ultrasound and cavography findings
doi:10.2478/v10019-008-0020-6 case report Obliterative hepatocavopathy ultrasound and cavography findings Ramazan Kutlu Department of Radiology, Inonu University School of Medicine, Malatya, Turkey ackgound.
More informationStenoses of Vascular Anastomoses After Hepatic Transplantation: Treatment with Balloon Angioplasty
167 Stenoses of Vascular Anastomoses After Hepatic Transplantation: Treatment with Balloon Angioplasty Nigel Raby1 Vascular complications after liver transplantation include occlusion or stenosis at the
More informationDenver Shunts vs TIPS for Ascites
Denver Shunts vs TIPS for Ascites Hooman Yarmohammadi MD Assistant Professor of Radiology Interventional Radiology & Image Guided Therapies Memorial Sloan-Kettering Cancer Center, New York, USA Hooman
More informationPortal vein stent placement for the treatment of postoperative portal vein stenosis: long-term success and factor associated with stent failure
Kato et al. BMC Surgery (2017) 17:11 DOI 10.1186/s12893-017-0209-y RESEARCH ARTICLE Portal vein stent placement for the treatment of postoperative portal vein stenosis: long-term success and factor associated
More informationبسم الله الرحمن الرحيم أوتيتم من العلم إال قليال وما
بسم الله الرحمن الرحيم أوتيتم من العلم إال قليال وما 1 2 Goals of the Lecture: What is the portal vein? How common is PVT? What conditions are associated with PVT? How does patient with PVT present? How
More informationINTRAHEPATIC PSS: AN INTERVENTIONALIST S PERSPECTIVE
INTRAHEPATIC PSS: AN INTERVENTIONALIST S PERSPECTIVE Matthew W. Beal, DVM, DACVECC College of Veterinary Medicine, Michigan State University, East Lansing, MI Key Points: Percutaneous transjugular coil
More informationTitle: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication
Title: Cholestasis after TIPS placement in a patient with primary sclerosing cholangitis: an uncommon complication Authors: Alejandro Salagre García, Carolina Muñoz Codoceo, Elena Gómez Domínguez, Inmaculada
More informationÓ Journal of Krishna Institute of Medical Sciences University 69
ISSN 2231-4261 ORIGINAL ARTICLE A Cadaveric Study of Portal Vein Termination and Its Surgical Relevance 1* 2 1 Shilpa N. Gosavi, Surekha D. Jadhav, Rajendra S. Garud 1 Department of Anatomy, Bharati Vidyapeeth
More informationC. CT scan shows ascites and thin enhancing parietal peritoneum
291 A B Fig. 1. A 55-year-old gastric cancer patient with peritoneal carcinomatosis. At surgery, there was large amount of ascites in peritoneal cavity and there were multiple small metastatic nodules
More informationSample page. POWER UP YOUR CODING with Optum360, your trusted coding partner for 32 years. Visit optum360coding.com.
2018 Complete Guide for Interventional Radiology An in-depth guide to interventional radiology coding, billing, and reimbursement for facilities and physicians POWER UP YOUR CODING with Optum360, your
More informationReview Article. Transjugular intrahepatic portosystemic stent shunt R. JALAN, D. N. REDHEAD, P. C. HAYES
15 Review Article Transjugular intrahepatic portosystemic stent shunt R. JALAN, D. N. REDHEAD, P. C. HAYES ABSTRACT The transjugular intrahepatic portosystemic stent shunt (TIPSS) is essentially a side-to-side
More informationPAPER. Role, Indications, and Utility in the Era of Liver Transplantation
Distal Splenorenal Shunt PAPER Role, Indications, and Utility in the Era of Liver Transplantation Roger L. Jenkins, MD; Roberto Gedaly, MD; James J. Pomposelli, MD, PhD; Elizabeth A. Pomfret, MD, PhD;
More informationVisceral aneurysm. Diagnosis and Interventions M.NEDEVSKA
Visceral aneurysm Diagnosis and Interventions M.NEDEVSKA History 1953 De Bakeyand Cooley Visceral aneurysm VAAs rare, reported incidence of 0.01 to 0.2% on routine autopsies. Clinically important Potentially
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationDirect Intrahepatic Porta-Caval Shunt Technique & Tips-Tricks. Pierre GOFFETTE, MD, St-Luc University Hospital University of Leuven Brussels
Direct Intrahepatic Porta-Caval Shunt Technique & Tips-Tricks Pierre GOFFETTE, MD, St-Luc University Hospital University of Leuven Brussels Pierre Goffette, M.D. Consultant/Advisory Board: Covidien (Neuro)
More informationCase Report INTRODUCTION CASE REPORT
Case Report J Korean Soc Transplant 2016;30:89-93 http://dx.doi.org/10.4285/jkstn.2016.30.2.89 Late Hepatic Venous Outflow Obstruction Following Inferior Vena Cava Stenting in Patient with Deceased Donor
More informationLeft-sided portal hypertension with a patent splenic vein: An impossible or a not-so-uncommon scenario?
Khan et al. 108 CASE REPORT PEER REVIEWED OPEN ACCESS Left-sided portal hypertension with a patent splenic vein: An impossible or a not-so-uncommon scenario? Iftikhar Khan, Ghassan Ramahi, Saif Zaabi,
More informationTransjugular Intrahepatic Portosystemic Shunt (TIPS) - What Radiologists Should Know
Transjugular Intrahepatic Portosystemic Shunt (TIPS) - What Radiologists Should Know Award: Certificate of Merit Poster No.: C-1508 Congress: ECR 2016 Type: Educational Exhibit Authors: E. Nagaya, F. T.
More informationQuality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Cardiovasc Intervent Radiol (2012) 35:1295 1300 DOI 10.1007/s00270-012-0493-y CIRSE STANDARDS OF PRACTICE GUIDELINES Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
More informationPolytetrafluoroethylene Covered Stent: Results of an Italian Multicenter Study
TIPS with Expanded Covered Stent Interventional Radiology Original Research Claudio Vignali 1 Irene Bargellini 1 Maurizio Grosso 2 Giovanni Passalacqua 3 Franco Maglione 4 Fulvio Pedrazzini 2 Pietro Filauri
More informationDOTTORATO DI RICERCA IN SCIENZE MEDICO-CHIRURGICHE GASTROENTEROLOGICHE E DEI TRAPIANTI TITOLO TESI FACTORS PREDICTING MORTALITY AFTER TIPS FOR
Alma Mater Studiorum Università di Bologna DOTTORATO DI RICERCA IN SCIENZE MEDICO-CHIRURGICHE GASTROENTEROLOGICHE E DEI TRAPIANTI Ciclo XXII Settore/i scientifico-disciplinare/i di afferenza: MED/12 TITOLO
More informationFollow this and additional works at:
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2017 Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde
More informationInterventional treatment of mesenteric venous occlusion.
Interventional treatment of mesenteric venous occlusion. Wichman, Heather J; Cwikiel, Wojciech; Keussen, Inger Published in: Polish journal of radiology / Polish Medical Society of Radiology DOI: 10.12659/PJR.890990
More informationFig. 1. Ileal and jejunal metastases from adenocarcinoma of the lung in 62-year-old male with a clinical history of bloody stool. A.
507 A B Fig. 1. Ileal and jejunal metastases from adenocarcinoma of the lung in 62-year-old male with a clinical history of bloody stool. A. An intraluminal polypoid mass (arrow) is seen in the dilated
More informationCurrent status of transjugular
Postgrad MedJ7 1998;74:716-720 C The Fellowship of Postgraduate Medicine, 1998 New techniques in medicine Summary The use of the transjugular intrahepatic portosystemic shunt (TIPS) has emerged as an important
More informationfollowing the last documented transfusion; thereafter, evaluate the residual impairment(s).
Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood
More informationRelative Values for Physicians. Relative Value Studies, Inc.
Relative Values for Physicians Relative Value Studies, Inc. Contents Contents...1 Introduction...1 User Guide... 1 Definitions of Terms in Relative Values for Physicians... 1 The Global Period... 2 Services
More informationTable 1 Cases studied
Fig. 1 Intra-operative measurements using the ultrasonic Doppler duplex sys temin a patient with idiopathic portal hypertension. The shunt blood flow was measured at the splenic hilus just after the shunt
More informationEndoscopic sclerotherapy: A risk factor for splanchnic venous thrombosis
Endoscopic sclerotherapy: A risk factor for splanchnic venous thrombosis Steven D. Leach, MD, George H. Meier, MD, and Richard J. Gusberg, MD, New Haven, Conn. Endoscopic sclerotherapy has been widely
More informationAS BETTER medical care allows. Splenorenal Shunt. An Ideal Procedure in the Pacific. See Invited Critique at end of article ORIGINAL ARTICLE
Splenorenal Shunt ORIGINAL ARTICLE An Ideal Procedure in the Pacific Linda L. Wong, MD; Cedric Lorenzo, MD; Whitney M. Limm, MD; Livingston M. Wong, MD Hypothesis: Splenorenal shunt, an accepted treatment
More informationThe Value of Renal Artery Resistive Indices: Association with
The Value of Renal Artery Resistive Indices: Association with Esophageal Variceal Bleeding in Patients with Alcoholic Cirrhosis 1 Joo Nam Byun, M.D., Dong Hun Kim, M.D. Purpose: To determine whether resistive
More informationCarvedilol or Propranolol in the Management of Portal Hypertension?
Evidence Based Case Report Carvedilol or Propranolol in the Management of Portal Hypertension? Arranged by: dr. Saskia Aziza Nursyirwan RESIDENCY PROGRAM OF INTERNAL MEDICINE DEPARTMENT UNIVERSITY OF INDONESIA
More informationProspective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts
More informationCase Report Inferior Vena Cava Torsion and Stenosis Complicated by Compressive Pericaval Regional Ascites following Orthotopic Liver Transplantation
Case Reports in Radiology Volume 2013, Article ID 576092, 4 pages http://dx.doi.org/10.1155/2013/576092 Case Report Inferior Vena Cava Torsion and Stenosis Complicated by Compressive Pericaval Regional
More informationSERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES
SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES YEON SEOK SEO, 1 SOO YOUNG PARK, 2 MOON YOUNG KIM, 3 SANG GYUNE KIM, 4 JUN YONG PARK, 5 HYUNG JOON YIM,
More informationGastro-Intestinal Bleeding- Interventional Radiology turning off the tap. Simon McPherson, Vascular Interventional Radiologist, Leeds
Gastro-Intestinal Bleeding- Interventional Radiology turning off the tap Simon McPherson, Vascular Interventional Radiologist, Leeds Scale UK 100,000 /year Commonest Vascular IR on-call 75% UGIB 65% NVUGIB
More informationReview Article Role of Self-Expandable Metal Stents in Acute Variceal Bleeding
Hindawi Publishing Corporation International Journal of Hepatology Volume 2012, Article ID 418369, 6 pages doi:10.1155/2012/418369 Review Article Role of Self-Expandable Metal Stents in Acute Variceal
More informationStudies on the Results of the Nonshunting Procedures for Portal Hypertension*)
Hiroshima Journal of Medical Sciences Vol. 32, No. 3, 241,...,246, September, 1983 HIJM 32-38 241 Studies on the Results of the Nonshunting Procedures for Portal Hypertension*) Motomu KODAMA, Tsuneo TAN
More informationGI bleeding in chronic liver disease
GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old
More informationManagement of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide
Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications
More informationTransjugular intrahepatic portosystemic shunt (TIPS) Information for patients Sheffield Vascular Institute
Transjugular intrahepatic portosystemic shunt (TIPS) Information for patients Sheffield Vascular Institute You have been given this leaflet because you need a procedure called a transjugular intrahepatic
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationThrombocytopenia and Chronic Liver Disease
Thrombocytopenia and Chronic Liver Disease Severe thrombocytopenia (platelet count
More informationCeliac Axis Stenosis: Incidence and Etiologies in Asymptomatic Individuals
Celiac Axis Stenosis: Incidence and Etiologies in Asymptomatic Individuals Chang Min Park, MD Jin Wook Chung, MD Hyun Beom Kim, MD Sang June Shin, MD Jae Hyung Park, MD Index terms: Arteries, stenosis
More informationEDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,
More informationLiver Transplantation
1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation
More informationEsophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph
Esophageal Varices Beta-Blockers or Band Ligation Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph Esophageal Varices Beta-Blockers or Band Ligation? Risk of esophageal variceal
More informationV ariceal bleeding is a serious complication of portal
431 LIVER Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal
More informationChanges in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10-Year Experience in Gangwon Province, South Korea
Gut and Liver, Vol. 6, No. 4, October 2012, pp. 476481 ORiginal Article Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10Year Experience in Gangwon Province, South Korea
More informationCOPYRIGHTED MATERIAL. 1 Approach to the patient with gross gastrointestinal bleeding. Grace H. Elta, Mimi Takami
1 Approach to the patient with gross gastrointestinal bleeding Grace H. Elta, Mimi Takami Gastrointestinal (GI) bleeding is a common clinical problem that requires more than 300 000 hospitalizations annually
More informationManagement of Extensive Portal Vein Thrombosis
Management of Extensive Portal Vein Thrombosis Deok-Bog Moon, Sung-Gyu Lee, Chul-Soo Ahn, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Kyu-Bo Sung 1, Gi- Young Ko 1, Dong-Il Kweon
More informationFactors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years Experience from a Single Tertiary Medical Center
Factors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years Experience from a Single Tertiary Medical Center Jen-Jung Pan, MD, PhD, Chaoru Chen, PhD, James G. Caridi,
More informationLIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.
LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,
More information4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions
Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What
More informationRG Volume 33 Number 5 Kirby et al 1497
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. RG Volume 33 Number
More informationHepatic Venography and Wedge Hepatic Vein Pressure Measurements in Diffuse Liver Disease
Hepatic Venography and Wedge Hepatic Vein Pressure Measurements in Diffuse Liver Disease JOHN A. CAVALUZZI,1 ROBERT SHEFF,1 DONALD P. HARRINGTON,1 STEPHEN L. KAUFMAN,1 KLEMENS BARTH,1 WILLIS C. MADDREY,2
More informationEvaluation and Management of Transjugular Intrahepatic Portosystemic Shunts
Vascular and Interventional Radiology Review Darcy Evaluation and Management of TIPS Vascular and Interventional Radiology Review Michael Darcy 1 Darcy M FOCUS ON: Keywords: portal hypertension, transjugular
More informationRisk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
Oregon Health & Science University OHSU Digital Commons Scholar Archive 9-2014 Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
More informationThe Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS)
n The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS) Information for patients Your liver doctor has recommended that you have a Transjugular Intrahepatic Portosystemic
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationPORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications
PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications Edy G. Trujillo, RN, MSN, ACNP-BC Liver Transplant RRUCLA Medical Center July 31, 2018 What Do We All Look Forward
More information